|
| Pronunciation |
 (ir
be SAR tan & hye droe klor oh
THYE a zide) |
 |
| U.S. Brand Names |
| Avapro® HCT |
|
| Synonyms |
| Hydrochlorothiazide and Irbesartan |
|
| Pharmacological Index |
|
Antihypertensive Agent, Combination |
|
| Use |
|
Combination therapy for the management of hypertension |
|
| Pregnancy Risk Factor |
|
C/D (2nd and 3rd trimesters) |
|
| Dental Health: Local Anesthetic/Vasoconstrictor Precautions |
|
No information available to require special precautions |
|
| Dental Health: Effects on Dental Treatment |
|
No effects or complications reported |
|
| Patient Information |
|
See individual agents. Pregnancy/breast-feeding precautions: Inform prescriber if you are or intend to be pregnant. Do not breast-feed. |
|
| Dosage Forms |
|
Tablet: Irbesartan 75 mg and hydrochlorothiazide 12.5 mg; irbesartan 150 mg and hydrochlorothiazide 12.5 mg; irbesartan 300 mg and hydrochlorothiazide 12.5 mg |
|
|
|
Copyright © 1978-2000 Lexi-Comp Inc. All Rights Reserved
